Korea holds training programme on vaccines and biologics

The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of Korea as the operator of 2022 Global Bio-Intensive Training Courses’ to provide workforce training in vaccine and biologics R&D and manufacturing for students from lowand middle-income countries (LMICs) and Korea. The training courses, the first of its kind global programme supported by the Government of Korea, aim to provide essential, practical knowledge through an intensive short-term programme designed to strengthen students’ professional capacity. Accordingly, the new programme will include offline and online courses on biologics development and manufacturing and on standard practice (GxP), plus onsite training and consultation. Funded with a KRW4.3 billion won ($3.6 million) grant from MOHW, the programme will provide 450 trainees (including 300 from LMICs) with comprehensive education designed to equip them with necessary skills in the development and production of biopharmaceuticals. Online courses will also be made available to additional trainees.